Both TRBC1-restricted and TRBC2-restricted tumors were observed in all disease categories studied, with an overall higher incidence of TRBC2+ neoplasms (73%, 95% CI: 60–83%) as expected by the slight overrepresentation of TRBC2 in the normal T-cell repertoire. The gene discussed is TRBC2; the disease is neoplasm.